ECL vs PACS · P/E 35, rev $8.48B vs P/E 23, rev $5.29B
Ecolab Inc (ECL) versus PACS Group, Inc. (PACS) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported PACS revenue for 2025-12-31 was $5.29B. Net income was $191.5M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
Not investment advice. Open the ECL and PACS stock pages for the full models.
Not investment advice.